HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

F L Giesel Selected Research

(DOTA(0)-Phe(1)-Tyr(3))octreotide (SMT 487)

6/2015SUV of [68Ga]DOTATOC-PET/CT Predicts Response Probability of PRRT in Neuroendocrine Tumors.
3/2015Comparison of 68Ga-DOTATOC biodistribution in patients with and without spleenectomy.
11/2014²¹³Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience.
6/2013Contrast-enhanced ultrasound monitoring of perfusion changes in hepatic neuroendocrine metastases after systemic versus selective arterial 177Lu/90Y-DOTATOC and 213Bi-DOTATOC radiopeptide therapy.
10/2012Comparison of neuroendocrine tumor detection and characterization using DOTATOC-PET in correlation with contrast enhanced CT and delayed contrast enhanced MRI.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


F L Giesel Research Topics

Disease

9Neoplasms (Cancer)
06/2015 - 08/2001
5Neoplasm Metastasis (Metastasis)
06/2015 - 10/2012
4Neuroendocrine Tumors (Neuroendocrine Tumor)
06/2015 - 10/2012
2Prostatic Neoplasms (Prostate Cancer)
06/2013 - 04/2013
1Thyroid Neoplasms (Thyroid Cancer)
10/2014
1Insulinoma
10/2014
1Carcinoma (Carcinomatosis)
04/2013
1Lymphoma (Lymphomas)
04/2012
1Cicatrix (Scar)
04/2012
1Pneumothorax
01/2012
1Takotsubo Cardiomyopathy
04/2010
1Cholestasis
04/2010
1Astrocytoma (Pilocytic Astrocytoma)
09/2007
1Brain Neoplasms (Brain Tumor)
02/2004
1Necrosis
02/2004
1Body Weight (Weight, Body)
10/2001

Drug/Important Bio-Agent (IBA)

5(DOTA(0)-Phe(1)-Tyr(3))octreotide (SMT 487)IBA
06/2015 - 10/2012
3Somatostatin Receptors (Somatostatin Receptor)IBA
06/2015 - 10/2012
2Peptide Receptors (Peptide Receptor)IBA
06/2015 - 06/2013
2Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
03/2015 - 11/2014
2GalliumIBA
06/2013 - 04/2013
2Carbon MonoxideIBA
04/2013 - 09/2007
13-Tyr-octreotideIBA
06/2015
1Glucagon-Like Peptide 1 (GLP 1)IBA
10/2014
1RadiopharmaceuticalsIBA
10/2014
1medullary Thyroid cancerIBA
10/2014
1IodineIBA
10/2014
1human glutamate carboxypeptidase IIIBA
04/2013
1N,N'- bis(2- hydroxy- 5- (ethylene- beta- carboxy)benzyl)ethylenediamine N,N'-diacetic acidIBA
04/2013
1LigandsIBA
04/2013
1gadolinium ethoxybenzyl DTPAIBA
10/2012
1ThymidineIBA
04/2012
1Glucose (Dextrose)FDA LinkGeneric
08/2010
1PlasticsIBA
04/2010
1gadobenic acid (gadobenate dimeglumine)FDA Link
10/2001
1GadoliniumIBA
08/2001

Therapy/Procedure

3Drug Therapy (Chemotherapy)
04/2012 - 02/2004
1Intra-Arterial Infusions
11/2014
1Chest Tubes (Chest Tube)
01/2012
1Anesthesia
04/2010
1Stents
04/2010